Valproate-induced panhypogammaglobulinemia
Authors:
- 14 July 2012
- journal article
- letter
- Published by Springer Nature in Neurological Sciences
- Vol. 34 (6) , 1003-1004
Abstract
Valproate is one of the most used anti-epileptic drugs. Its common side effects are nausea, vomiting, weight gain, hair loss, tremor, changes in behavior, slowed thinking and impaired liver function. Blood dyscrasias are also relatively frequent and a few studies reported changes in serum immunoglobulin concentrations with valproate treatment. We describe a case of panhypogammaglobulinemia with transient pancytopenia due to valproate. Pancytopenia was recovered after discontinuation of valproate but panhypogammaglobulinemia has been persisting. Intravenous immunoglobulin is being administrated monthly. Previous reports describe that other sodium channel blockers, such as phenytoin and carbamazepine, have been associated with hypogammaglobulinemia. This report also suggests that immunodeficiencies can be caused by valproate.Keywords
This publication has 5 references indexed in Scilit:
- Carbamazepine-induced hypogammaglobulinemiaSeizure: European Journal of Epilepsy, 2012
- Serum IgA, IgG, and IgM concentrations in patients with epilepsy and matched controls: a cohort-based cross-sectional studyEpilepsy & Behavior, 2005
- Lamotrigine-induced common variable immune deficiencyNeurology, 2004
- Immunoglobulins in children with epilepsy: the Dutch Study of Epilepsy in ChildhoodClinical and Experimental Immunology, 2003
- Reversible Common Variable Immunodeficiency Syndrome Induced by PhenytoinArchives of internal medicine (1960), 1989